02
By The Numbers*
50+
Our technology is backed by over 50 patents, protecting and advancing exclusive imaging and endoscopic capabilities.
Patents For Advancing Imaging and Endoscopic Capabilities
10x
Our single-use design is crafted with the goal of reducing cross-contamination risks by up to 10 times the current rate, supporting safer procedures for patients.
We Aim To Reduce Cross-Contamination Risks
30%
Our technology is developed to help streamline complex procedures, with the potential to reduce operating time and improve patient throughput.
Possible Reduction In Procedure Time With Improved Efficiency
1
Our endoscope is designed to contribute to cost efficiency, with the possibility of just one additional procedure offering measurable ROI.
Procedure Aims To Cover The Entire Unit Investment
99.99%
Our device aims to achieve illumination efficiency far beyond standard CMOS cameras, working to provide clear and precise imaging for diagnostics.
Illumination Efficiency Potential vs. Traditonal CMOS Solutions
40%
Our advanced imaging technology aspires to support higher success rates with the goal of improving patient outcomes.
Aiming For Higher Success Rates In Complex Cases
* Source: JACC: Cardiovascular Interventions. "Chronic Total Occlusion Percutaneous Coronary Interventions: Evidence, Techniques, and Outcomes." Accessed at https://www.jacc.org/doi/full/10.1016/j.jcin.2009.02.008.
SPEAKER:
Dr. Luis Savastano
DATE:
October 28, 2025
TIME:
1:00 PM – 2:00 PM, Tuesday, October 28, 2025
LOCATION:
San Francisco, CA
We are proud to share that Dr. Luis Savastano, Professor at the University of California, San Francisco (UCSF), will present his scientific abstract at TCT 2025, featuring research conducted with VerAvanti’s Scanning Fiber Endoscope (SFE).
Featured Presentation
About TCT 2025
The 37th Annual Transcatheter Cardiovascular Therapeutics Conference: Igniting INNOVATION, EDUCATION, and CONNECTION
Founded by Dr. Martin B. Leon, the Transcatheter Cardiovascular Therapeutics (TCT) conference is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) and the world’s foremost educational forum specializing in interventional cardiovascular medicine.
Debuting as a small gathering of 150 in 1988, TCT now attracts thousands of attendees from around the world. Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research.
The end goal: improving the survival and quality of life of patients suffering from heart and vascular disease.
At TCT 2025, the power of Acute Interventions takes center stage, highlighting the lifesaving procedures, breakthrough technologies, and cutting-edge research driving the next era of cardiovascular care. From emergency PCI and primary angioplasty to timely valvular and endovascular interventions in some of our most critically ill patients, this year’s program delivers real-world innovation and expert-driven insights, enhancing rapid-response treatments and improving patient outcomes.